Test Price
2,800 AED✅ Home Collection Available
TCTN1 Gene Joubert Syndrome Type 13 Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين TCTN1 لمتلازمة جوبيرت النوع 13 في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
ملخص تنفيذي: اختبار جيني دقيق بنسبة 99.9% للكشف عن طفرات جين TCTN1 المرتبطة بمتلازمة جوبيرت النوع 13، معتمد من هيئة الصحة بدبي ومتوافق مع المرسوم بقانون اتحادي رقم 41 لسنة 2024.
- ✓ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
- ✓ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain and VIP Mobile Phlebotomy
- ✓ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation
- ✓ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Overview
This test uses Next Generation Sequencing (NGS) to analyze all coding exons and splice sites of the TCTN1 gene, identifying pathogenic variants responsible for Joubert syndrome type 13—a rare neurodevelopmental ciliopathy. يساعد هذا الاختبار في تشخيص متلازمة جوبيرت النوع 13 وتوجيه خطة العلاج والمتابعة المتعددة التخصصات.
| Feature | Our Test – NGS Advantage | Closest Alternative – Sanger Single-Gene |
|---|---|---|
| Methodology | Next Generation Sequencing (NGS) – full gene coverage | Traditional Sanger sequencing of selected exons only |
| Diagnostic Precision | >99.9% sensitivity for single nucleotide variants and small indels | ~95% sensitivity for targeted regions; may miss deep intronic or large rearrangements |
| Turnaround Time | 3–4 weeks | 6–8 weeks |
| Regulatory Compliance | ISO 9001:2015, DHA/MOHAP standards, UAE PDPL | May lack full UAE local accreditation |
UAE Regulatory Compliance & Data Protection
This test fully adheres to:
- Federal Decree-Law No. 41 of 2024 – Article 87: Genetic testing and counseling regulations
- CDS Law 2026 – Mandatory guardian consent for minors; all pediatric samples processed under legal protection
- UAE Personal Data Protection Law (PDPL) – Your genomic data is anonymized, encrypted, and never shared without explicit consent
- ISO 9001:2015 Certification (Cert: INT/EGQ/2509DA/3139) – Quality management across all steps
Licensed Facility No. 9834453 | DHA‑compliant reporting
Physician Insight & Safety Protocol
“This NGS assay provides definitive molecular confirmation of Joubert syndrome type 13, yet clinical correlation with neuroimaging and a thorough neurological exam remains essential. It is not a screening test; results must be interpreted by a specialized neurologist or clinical geneticist,” states Dr. Prabhakar Reddy (DHA License: 61713011).
“A non‑informative result does not exclude the diagnosis if the clinical suspicion is high; further testing may be warranted.”
“We strongly recommend pre‑ and post‑test genetic counseling to empower families with knowledge and support.”
Safety & Exclusion Criteria
- Exclusion: Patients who refuse a genetic counseling session prior to sample collection.
- Exclusion (Minors): Collection from a minor without valid, documented guardian consent (CDS Law 2026).
- Exclusion: Individuals unable to provide a viable DNA sample due to recent allogeneic bone marrow transplant.
- Emergency Red Flags: If the patient experiences new‑onset seizures, loss of consciousness, or acute breathing irregularities, seek immediate medical attention at the nearest emergency department – do not wait for test results.
Patient FAQ & Clinical Guidance
What does a positive TCTN1 mutation mean for my child?
A positive result confirms a diagnosis of Joubert syndrome type 13, requiring multidisciplinary neurological, ophthalmological, and renal follow‑up. النتيجة الإيجابية تؤكد تشخيص متلازمة جوبيرت النوع 13 وتستدعي متابعة متعددة التخصصات تشمل الأعصاب والعيون والكلى.
How is the sample collected and what is the turnaround time?
A painless blood draw or a single drop on FTA card is collected at home by a certified phlebotomist; results are ready in 3–4 weeks. يتم جمع عينة دم أو قطرة واحدة على بطاقة FTA من خلال سحب منزلي غير مؤلم على يد ممرض معتمد، وتصدر النتائج خلال 3 إلى 4 أسابيع.
Are there any risks or side effects associated with this genetic test?
The itself is non‑invasive with only minor discomfort; however, mandatory genetic counseling before testing is required by UAE law. الاختبار غير جراحي ولا يسبب مضاعفات تُذكر، لكن الاستشارة الوراثية قبل الفحص إلزامية بموجب القانون الإماراتي.
📞 For home collection booking or clinical queries, contact us on +971 54 548 8731 (WhatsApp) or call +971 54 548 8731. Support hours: 8 AM – 11 PM.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians